ABOS - Acumen Pharmaceuticals GAAP EPS of -$1.06 misses by $0.08
2023-03-27 07:04:55 ET
- Acumen Pharmaceuticals press release ( NASDAQ: ABOS ): FY GAAP EPS of -$1.06 misses by $0.08 .
- Cash, cash equivalents and marketable securities of $193.4 million as of Dec. 31, 2022 expected to be sufficient to support clinical and operational goals through 2025
For further details see:
Acumen Pharmaceuticals GAAP EPS of -$1.06 misses by $0.08